4 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $4.1B | -$34M | 5.9% | 2.6% | $57M | $2.2B | $125M |
| 2024 | $4.2B | -$222M | 5.5% | 0.2% | -$123M | $2.1B | $38M |
| 2023 | $4.2B | $48M | 10.8% | 6.4% | -$287M | $1.8B | $8M |
| 2022 | $4.7B | -$173M | 7.5% | 2.8% | -$436M | — | $35M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $1.0B | -$317M | -8.5% | -16.6% | -$99M | $2.3B | $139M |
| Dec '25 | $1.0B | -$37M | -0.3% | -6.2% | $104M | $2.2B | $125M |
| Sep '25 | $1.1B | $313M | 34.7% | 30.0% | $92M | $2.3B | $95M |
| Jun '25 | $1.0B | -$148M | -4.2% | -9.8% | -$11M | $2.4B | $111M |
| Mar '25 | $994M | -$162M | -8.2% | -4.9% | -$47M | $2.4B | $123M |
| Dec '24 | $950M | -$41M | 8.8% | 2.4% | -$28M | $2.1B | $38M |
| Sep '24 | $1.1B | -$101M | 0.4% | -5.2% | -$32M | $2.1B | $35M |
| Jun '24 | $1.1B | -$39M | 5.6% | 0.5% | $52M | — | $7M |
| Mar '24 | $1.0B | -$42M | 7.8% | 3.6% | -$114M | — | $24M |
| Dec '23 | $977M | -$48M | 2.3% | -1.4% | -$39M | $1.8B | $8M |
| Sep '23 | $1.1B | $100M | 22.8% | 18.5% | — | — | $14M |
How the market has priced CLMT against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 3 years, Calumet, Inc. /De's revenue has declined 4.1% per year. These are computed facts, not advice.
As of FY2025, Calumet, Inc. /De reported $2.2B of total debt against $125M of cash; operating income covered interest expense 0.5×.
In FY2025, gross margin was 5.9%, operating margin 2.6%, and net margin -0.8%.
As of Jun '26, Calumet, Inc. /De traded at a price-to-earnings ratio of about 40.8× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.